Citations

Showing 10 of 108152 citations.

Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Lai, Jennifer C. , Bernal, William , Tapper, Elliot B. , Ekong, Udeme D. , Carey, Elizabeth J. , Tapper, Elliot B , Ekong, Udeme , Lai, Jennifer , Tandon, Puneeta , Dasarathy, Srinivasan

Mayo Clinic

Hepatology | July 7, 2021 | Volume: 74 | Issue: 3 | Pages: 1611-1644

10.1002/hep.32049 | PMID 34233031 Get It

Bone and soft tissue sarcomas in cerebrospinal fluid and effusion: A 20‐year review at our institution
Sharma, Anurag , Thangaiah, Judith Jebastin, Shetty, Sindhu , Policarpio‐Nicolas, Maria Luisa , Policarpio-Nicolas, Maria Luisa C

Mayo Clinic

Cancer Cytopathology | July 7, 2021 | Volume: 129 | Issue: 10 | Pages: 776-787

10.1002/cncy.22431 | PMID 34233079 Get It

BackgroundThe literature on bone and soft tissue sarcomas (BSTSs) involving effusions and cerebrospinal fluid (CSF) is very limited.MethodsA computerized search for fluid cytology with a sarcoma diagnosis from 2000 to 2020 was performed. All available cases, including the clinical follow‐up, were reviewed.ResultsA total of 57 fluids specimens from 36 BSTSs were identified (9 rhabdomyosarcomas, 6 angiosarcomas, 5 epithelioid hemangioendotheliomas, 3 dedifferentiated liposarcomas, 2 chondrosarcomas, 1 extraskeletal myxoid chondrosarcoma, 3 Ewing sarcomas, 2 undifferentiated sarcomas, 3 osteosarcomas, 1 synovial sarcoma, and 1 hybrid low‐grade fibromyxoid sarcoma/sclerosing epithelioid fibrosarcoma). There were 22 males and 14 females. The age range was 4 to 82 years (median, 45 years). Sites of involvement included pleural fluid (n = 38), peritoneal fluid (n = 14), and CSF (n = 5). Twenty‐four cytology cases were available for review. The cytologic features were nonspecific and ranged from dyshesive to clusters of round, epithelioid, pleomorphic, and occasionally spindle‐shaped malignant cells that could easily mimic other non‐BSTS malignant tumors. The diagnosis of BSTS was made by comparison with a prior specimen and/or ancillary studies (molecular or immunohistochemical stains). The prognosis was poor because 95% of the patients died of their disease.ConclusionsThe incidence of BSTS in fluid cytology is extremely rare, and it can have cytologic features similar to those of non‐BSTS malignancies. Although, in most cases, a comparison with a prior known BSTS specimen may suffice, the use of ancillary studies is extremely helpful in arriving at the correct diagnosis. However, in cases with no known prior malignancy, including BSTS in the differential diagnosis is prudent for preventing misdiagnosis.
Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma
Anderson, Nicole , Qin, Xiaodan , Finan, Jennifer M. , Lam, Andrew , Athoe, Jacob, Missiaen, Rindert , Skuli, Nicolas , Kennedy, Annie, Saini, Amandeep S. , Tao, Ting , Zhu, Shizhen , Nissim, Itzhak , Look, A. Thomas , Qing, Guoliang , Simon, M. Celeste , Feng, Hui , Tao, Ting , Anderson, Nicole M., Kennedy, Annie

Mayo Clinic

Cancer Research | July 7, 2021 | Volume: 81 | Issue: 17 | Pages: 4417-4430

10.1158/0008-5472.can-20-2153 | PMID 34233924 Get It

Abstract High-risk neuroblastoma remains therapeutically challenging to treat, and the mechanisms promoting disease aggression are poorly understood. Here, we show that elevated expression of dihydrolipoamide S-succinyltransferase (DLST) predicts poor treatment outcome and aggressive disease in patients with neuroblastoma. DLST is an E2 component of the α-ketoglutarate (αKG) dehydrogenase complex, which governs the entry of glutamine into the tricarboxylic acid cycle (TCA) for oxidative decarboxylation. During this irreversible step, αKG is converted into succinyl-CoA, producing NADH for oxidative phosphorylation (OXPHOS). Utilizing a zebrafish model of MYCN-driven neuroblastoma, we demonstrate that even modest increases in DLST expression promote tumor aggression, while monoallelic dlst loss impedes disease initiation and progression. DLST depletion in human MYCN-amplified neuroblastoma cells minimally affected glutamine anaplerosis and did not alter TCA cycle metabolites other than αKG. However, DLST loss significantly suppressed NADH production and impaired OXPHOS, leading to growth arrest and apoptosis of neuroblastoma cells. In addition, multiple inhibitors targeting the electron transport chain, including the potent IACS-010759 that is currently in clinical testing for other cancers, efficiently reduced neuroblastoma proliferation in vitro. IACS-010759 also suppressed tumor growth in zebrafish and mouse xenograft models of high-risk neuroblastoma. Together, these results demonstrate that DLST promotes neuroblastoma aggression and unveils OXPHOS as an essential contributor to high-risk neuroblastoma. Significance: These findings demonstrate a novel role for DLST in neuroblastoma aggression and identify the OXPHOS inhibitor IACS-010759 as a potential therapeutic strategy for this deadly disease.
The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Sharma, Neeraj , Smadbeck, James B. , Abdallah, Nadine , Zepeda‐Mendoza, Cinthya , Binder, Moritz , Pearce, Kathryn E., Asmann, Yan W. , Peterson, Jess F. , Greipp, Patricia T. , Bergsagel, P. Leif , Kumar, Shaji , Bergsagel, P. Leif , Binder, Moritz , Peterson, Jess F , Greipp, Patricia T , Ketterling, Rhett P. , Rajkumar, S. Vincent , Baughn, Linda B. , Sharma, Neeraj

Mayo Clinic

Clinical Cancer Research | July 7, 2021 | Volume: 27 | Issue: 19 | Pages: 5430-5439

10.1158/1078-0432.ccr-21-0005 | PMID 34233962 Get It

Abstract Purpose: Structural variants (SV) of the MYC gene region are common in multiple myeloma and influence disease progression. However, the prognostic significance of different MYC SVs in multiple myeloma has not been clearly established. Experimental Design: We conducted a retrospective study of multiple myeloma comparing MYC SV subtypes identified by next-generation sequencing (NGS) and FISH to MYC expression and disease survival using 140 cases from Mayo Clinic and 658 cases from the MMRF CoMMpass study. Results: MYC SVs were found in 41% of cases and were classified into nine subtypes. A correlation between the presence of a MYC SV and increased MYC expression was identified. Among the nine MYC subtypes, the non-immunoglobulin (non-Ig) insertion subtype was independently associated with improved outcomes, while the Ig insertion subtype, specifically involving the IgL gene partner, was independently associated with poorer outcomes compared with other MYC SV subtypes. Although the FISH methodology failed to detect approximately 70% of all MYC SVs, those detected by FISH were associated with elevated MYC gene expression and poor outcomes suggesting a different pathogenic role for FISH-detected MYC subtypes compared with other MYC subtypes. Conclusions: Understanding the impact of different MYC SVs on disease outcome is necessary for the reliable interpretation of MYC SVs in multiple myeloma. NGS approaches should be considered as a replacement technique for a more comprehensive evaluation of the multiple myeloma clone.
Hedgehog/GLI Signaling Pathway: Transduction, Regulation, and Implications for Disease
Sigafoos, Ashley N. , Paradise, Brooke D., Fernández-Zapico, Martín E. , Fernandez-Zapico, Martin E

Mayo Clinic

Cancers | July 7, 2021 | Volume: 13 | Issue: 14 | Pages: 3410

10.3390/cancers13143410 | PMID 34298625 Get It

The Hh/GLI signaling pathway was originally discovered in Drosophila as a major regulator of segment patterning in development. This pathway consists of a series of ligands (Shh, Ihh, and Dhh), transmembrane receptors (Ptch1 and Ptch2), transcription factors (GLI1–3), and signaling regulators (SMO, HHIP, SUFU, PKA, CK1, GSK3β, etc.) that work in concert to repress (Ptch1, Ptch2, SUFU, PKA, CK1, GSK3β) or activate (Shh, Ihh, Dhh, SMO, GLI1–3) the signaling cascade. Not long after the initial discovery, dysregulation of the Hh/GLI signaling pathway was implicated in human disease. Activation of this signaling pathway is observed in many types of cancer, including basal cell carcinoma, medulloblastoma, colorectal, prostate, pancreatic, and many more. Most often, the activation of the Hh/GLI pathway in cancer occurs through a ligand-independent mechanism. However, in benign disease, this activation is mostly ligand-dependent. The upstream signaling component of the receptor complex, SMO, is bypassed, and the GLI family of transcription factors can be activated regardless of ligand binding. Additional mechanisms of pathway activation exist whereby the entirety of the downstream signaling pathway is bypassed, and PTCH1 promotes cell cycle progression and prevents caspase-mediated apoptosis. Throughout this review, we summarize each component of the signaling cascade, non-canonical modes of pathway activation, and the implications in human disease, including cancer.
Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer
Renuse, Santosh , Madamsetty, Vijay Sagar , Madugundu, Anil K. , Singh, Smrita , Udainiya, Savita, Mangalaparthi, Kiran K. , Kim, Min‐Sik , Liu, Ren , Krasnoperov, Valery, Truty, Mark J. , Graham, Rondell P. , Gill, Parkash S. , Mukhopadhyay, Debabrata , Pandey, Akhilesh , Madamsetty, Vijay S , Singh, Smrita , Truty, Mark, Mukhopadhyay, Debabrata , Pandey, Akhilesh , Kim, Min-Sik , Pandey, Akhilesh , Graham, Rondell P , Mun, Dong‐Gi , Kumar, S. Ram

Mayo Clinic

Cancers | July 7, 2021 | Volume: 13 | Issue: 14 | Pages: 3404

10.3390/cancers13143404 | PMID 34298619 Get It

Pancreatic ductal adenocarcinoma is a recalcitrant tumor with minimal response to conventional chemotherapeutic approaches. Oncogenic signaling by activated tyrosine kinases has been implicated in cancers resulting in activation of diverse effector signaling pathways. Thus, the discovery of aberrantly activated tyrosine kinases is of great interest in developing novel therapeutic strategies in the treatment and management of pancreatic cancer. Patient-derived tumor xenografts (PDXs) in mice serve as potentially valuable preclinical models as they maintain the histological and molecular heterogeneity of the original human tumor. Here, we employed high-resolution mass spectrometry combined with immunoaffinity purification using anti-phosphotyrosine antibodies to profile tyrosine phosphoproteome across 13 pancreatic ductal adenocarcinoma PDX models. This analysis resulted in the identification of 1199 tyrosine-phosphorylated sites mapping to 704 proteins. The mass spectrometric analysis revealed widespread and heterogeneous activation of both receptor and non-receptor tyrosine kinases. Preclinical studies confirmed ephrin type-B receptor 4 (EphB4) as a potential therapeutic target based on the efficacy of human serum albumin-conjugated soluble EphB4 in mice bearing orthotopic xenografts. Immunohistochemistry-based validation using tissue microarrays from 346 patients with PDAC showed significant expression of EphB4 in >70% of patients. In summary, we present a comprehensive landscape of tyrosine phosphoproteome with EphB4 as a promising therapeutic target in pancreatic ductal adenocarcinoma.
Dabigatran and Remdesivir Synergistically Inhibit Coronavirus Replication
Nelson, Alfred D. , Bi, Yan , Ji, Baoan

Mayo Clinic

No container title available | July 7, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-600798/v1 Get It

Abstract Background & Aims: Coronavirus-19 (COVID-19) due to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) is an ongoing global pandemic causing more than three million deaths. Protease inhibitors had been shown to decrease viral entry. However, the role of dabigatran, an inhibitor of multiple proteases, on coronavirus remains unknown.Methods: MRC-5 cells, HCT-8, or Huh-7 cells were infected with Beta-coronavirus OC43 and SARS-CoV-2. Cytopathic effects (CPE) were monitored by imaging. Viral load was measured by quantitative RT-PCR. Viral protein was detected by Western blot.Results: Camostat, a serine protease inhibitor, had no effect on the replication of OC43 and SARS CoV-2 even at higher doses. Dabigatran inhibited replication, viral entry and CPE of OC43 in a dose-dependent manner. Dabigatran and Remdisivir synergistically inhibited OC43 virus replication. Conclusions: Dabigatran may be beneficial in treating SARS-CoV-2 both for anticoagulation and viral replication inhibition need to be evaluated further.
Magnetic Resonance Imaging Correlates of Multiple Sclerosis Immunopathological Patterns
Metz, Imke , Gavrilova, Ralitza H. , Weigand, Stephen D. , Popescu, Bogdan , Guo, Yong , Gloth, Mareike, Tobin, W. Oliver , Zalewski, Nicholas L. , Tillema, Jan Mendelt, Parisi, Joseph E. , Becker, Stéphanie , König, Fatima, Brück, Wolfgang , Lucchinetti, Claudia F. , Tobin, William Oliver, Tillema, Jan M, Tobin, W Oliver , Frischer, Josa M. , Lassmann, Hans , Erickson, Bradley J. , Becker, Stephanie

Mayo Clinic

Annals of Neurology | July 7, 2021 | Volume: 90 | Issue: 3 | Pages: 440-454

10.1002/ana.26163 | PMID 34231919 Get It

ObjectiveHistology reveals that early active multiple sclerosis lesions can be classified into 3 main interindividually heterogeneous but intraindividually stable immunopathological patterns of active demyelination (patterns I–III). In patterns I and II, a T‐cell‐ and macrophage‐associated demyelination is suggested, with pattern II only showing signs of a humoral immune response. Pattern III is characterized by inflammatory lesions with an oligodendrocyte degeneration. Patterns suggest pathogenic heterogeneity, and we postulated that they have distinct magnetic resonance imaging (MRI) correlates that may serve as biomarkers.MethodsWe evaluated in an international collaborative retrospective cohort study the MRI lesion characteristics of 789 conventional prebiopsy and follow‐up MRIs in relation to their histopathologically classified immunopathological patterns (n = 161 subjects) and lesion edge features (n = 112).ResultsA strong association of a ringlike enhancement and a hypointense T2‐weighted (T2w) rim with patterns I and II, but not pattern III, was observed. Only a fraction of pattern III patients showed a ringlike enhancement, and this was always atypical. Ringlike enhancement and T2w rims colocalized, and ringlike enhancement showed a strong association with macrophage rims as shown by histology. A strong concordance of MRI lesion characteristics, meaning that different lesions showed the same features, was found when comparing biopsied and nonbiopsied lesions at a given time point, indicating lesion homogeneity within individual patients.InterpretationWe provide robust evidence that MRI characteristics reflect specific morphological features of multiple sclerosis immunopatterns and that ringlike enhancement and T2w hypointense rims might serve as a valuable noninvasive biomarker to differentiate pathological patterns of demyelination. ANN NEUROL 2021;90:440–454
On the importance of quality assurance (QA) for COMS eye plaque Silastic inserts: A guide to measurement methods, typical variations, and an example of how QA intercepted a manufacturing aberration
Oare, Courtney, Deufel, Christopher L. , Cutsinger, Jordan McCauley , Herman, Tania De La Fuente, Ferreira, Clara , McCauley Cutsinger, Jordan

Mayo Clinic

Journal of Applied Clinical Medical Physics | July 7, 2021 | Volume: 22 | Issue: 8 | Pages: 72-82

10.1002/acm2.13325 | PMID 34231949 Get It

AbstractPurposeEye plaques are widely used for ocular melanoma and provide an effective alternative to enucleation with adequate tumor control. A COMS plaque utilizes a Silastic insert for precise positioning of the radioactive seeds with respect to the scleral surface of the eye; however, due to manufacturing variability, the insert may unintentionally increase or decrease the distance between the sources and tumor. The purpose of this work is to provide guidance in measuring and identifying outliers in Silastic inserts. The importance of regular quality assurance (QA) is illustrated in an experience where a systematic problem was detected and the manufacturer's 22‐mm mold was corrected.MethodsA detailed description of the molds and manufacturing process used to produce Silastic inserts is provided, including photographs of the process steps. The variability in Silastic insert production was evaluated by measuring the thickness of 124 Silastic inserts. An estimate of how the observed Silastic thickness discrepancies impact the dose to the tumor and critical eye structures was performed using homogeneous dose calculations. A standard QA protocol was developed to guide the clinical user.ResultsThickness of the measured Silastic inserts ranged from 1.22 to 2.67 mm, demonstrating variation from the 2.25 mm standard. Six of the 22‐mm inserts were outliers (Δthickness >3 standard deviations) and were excluded from the statistics. The outliers were investigated with the help of the manufacturer, who discovered that a systematic error was accidentally introduced into the 22‐mm mold.ConclusionsDue to manufacturing errors or variability, the Silastic inserts used in COMS eye plaques may be thicker or thinner than the design standard. Such variations may impact tumor control or increase the risk of normal tissue side effects. A standardized QA program is recommended to detect variations and communicate unusual findings to the manufacturer.
D-MANOVA: fast distance-based multivariate analysis of variance for large-scale microbiome association studies
Chen, Jun , Zhang, Xianyang , Chen, Jun

Mayo Clinic

Bioinformatics | July 7, 2021 | Volume: 38 | Issue: 1 | Pages: 286-288

10.1093/bioinformatics/btab498 | PMID 34255026 Get It

Abstract Summary PERMANOVA (permutational multivariate analysis of variance based on distances) has been widely used for testing the association between the microbiome and a covariate of interest. Statistical significance is established by permutation, which is computationally intensive for large sample sizes. As large-scale microbiome studies, such as American Gut Project (AGP), become increasingly popular, a computationally efficient version of PERMANOVA is much needed. To achieve this end, we derive the asymptotic distribution of the PERMANOVA pseudo-F statistic and provide analytical P-value calculation based on chi-square approximation. We show that the asymptotic P-value is close to the PERMANOVA P-value even under a moderate sample size. Moreover, it is more accurate and an order-of-magnitude faster than the permutation-free method MDMR. We demonstrated the use of our procedure D-MANOVA on the AGP dataset. Availability and implementation D-MANOVA is implemented by the dmanova function in the CRAN package GUniFrac. Supplementary information Supplementary data are available at Bioinformatics online.